Application and Research Progress of Self-Assembling Protein Nanoparticles in Vaccine Development

Area of Science:

• Biotechnology
• Immunology
• Materials Science

Background:

• Self-assembling protein nanoparticles (SPNPs) are emerging as a promising platform for vaccine development.
• Current research focuses on three main categories: virus-like particles (VLPs), natural protein nanoparticles, and computationally designed protein nanoparticles.

Purpose of the Study:

• To systematically review and compare the design strategies, immunogenicity, and applicability of different SPNP types for next-generation vaccines.
• To evaluate the potential of SPNPs in creating safer and more effective immunization strategies.

Main Methods:

• Systematic literature review of research on SPNPs for vaccine applications.
• Comparative analysis of VLPs, natural protein nanoparticles (ferritin, encapsulin), and designed protein nanoparticles.
• Evaluation of design principles, antigen presentation, and immune responses elicited by SPNPs.

Main Results:

• VLPs demonstrate robust humoral and cellular immunity due to virus-mimetic structures.
• Natural protein nanoparticles offer biocompatibility and controlled multivalent antigen presentation.
• Designed protein nanoparticles allow for structural optimization, tailored antigen display, and immune modulation.

Conclusions:

• SPNPs represent a versatile and powerful platform for rational vaccine design.
• Integrating natural and engineered principles in SPNPs opens new avenues for developing advanced vaccines.
• SPNP-based vaccines hold significant potential for enhancing safety and efficacy in immunization strategies.